These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10607376)

  • 1. Evaluation of the developmental toxicity of thalidomide using frog embryo teratogenesis assay-xenopus (FETAX): biotransformation and detoxification.
    Fort DJ; Stover EL; Bantle JA; Finch RA
    Teratog Carcinog Mutagen; 2000; 20(1):35-47. PubMed ID: 10607376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the developmental toxicity of benzo[a]pyrene and 2-acetylaminofluorene using Xenopus: modes of biotransformation. Stover Group.
    Propst TL; Fort DJ; Stover EL; Schrock B; Bantle JA
    Drug Chem Toxicol; 1997; 20(1-2):45-61. PubMed ID: 9183562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the developmental toxicity of 4-bromobenzene using frog embryo teratogenesis assay--Xenopus: possible mechanisms of action.
    Fort DJ; Propst TL; Stover EL
    Teratog Carcinog Mutagen; 1996; 16(6):307-15. PubMed ID: 9178453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the developmental toxicities of ethanol, acetaldehyde, and thioacetamide using FETAX.
    Fort DJ; McLaughlin DW; Rogers RL; Buzzard BO
    Drug Chem Toxicol; 2003 Feb; 26(1):23-34. PubMed ID: 12643038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of an exogenous metabolic activation system for FETAX. I. Post-isolation rat liver microsome mixtures.
    Fort DJ; Rogers RL; Stover EL; Finch RA
    Drug Chem Toxicol; 2001 May; 24(2):103-15. PubMed ID: 11360429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effects of glucose-6-phosphate and NADP against alpha-chaconine-induced developmental toxicity in Xenopus embryos.
    Rayburn JR; Bantle JA; Qualls CW; Friedman M
    Food Chem Toxicol; 1995 Dec; 33(12):1021-5. PubMed ID: 8846997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the developmental toxicity of trichloroethylene and detoxification metabolites using Xenopus.
    Fort DJ; Stover EL; Rayburn JR; Hull M; Bantle JA
    Teratog Carcinog Mutagen; 1993; 13(1):35-45. PubMed ID: 8100651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the mechanism of isoniazid-induced developmental toxicity with frog embryo teratogenesis assay: Xenopus (FETAX).
    Fort DJ; Bantle JA
    Teratog Carcinog Mutagen; 1990; 10(6):463-76. PubMed ID: 1982910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Frog Embryo Teratogenesis Assay-Xenopus and an exogenous metabolic activation system to evaluate the developmental toxicity of diphenylhydantoin.
    Fort DJ; Bantle JA
    Fundam Appl Toxicol; 1990 May; 14(4):720-33. PubMed ID: 2361573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the predictive validity of frog embryo teratogenesis assay-Xenopus (FETAX).
    Fort DJ; Stover EL; Farmer DR; Lemen JK
    Teratog Carcinog Mutagen; 2000; 20(2):87-98. PubMed ID: 10679752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the developmental toxicity of caffeine and caffeine metabolites using the frog embryo teratogenesis assay--Xenopus (FETAX).
    Fort DJ; Stover EL; Propst TL; Faulkner BC; Vollmuth TA; Murray FJ
    Food Chem Toxicol; 1998 Jul; 36(7):591-600. PubMed ID: 9687966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of an exogenous metabolic activation system for FETAX. II. Preliminary evaluation.
    Fort DJ; Rogers RL; Paul RR; Stover EL; Finch RA
    Drug Chem Toxicol; 2001 May; 24(2):117-27. PubMed ID: 11360430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Teratogenicity of Pharmaceuticals Using FETAX.
    Islas-Flores H; Pérez-Alvaréz I; Gómez-Oliván LM
    Methods Mol Biol; 2018; 1797():299-307. PubMed ID: 29896699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Xenopus tropicalis as an alternative test organism for frog embryo teratogenesis assay--Xenopus (FETAX).
    Song MO; Fort DJ; McLaughlin DL; Rogers RL; Thomas JH; Buzzard BO; Noll AM; Myers NK
    Drug Chem Toxicol; 2003 Aug; 26(3):177-89. PubMed ID: 12953658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the developmental toxicity of five compounds with the frog embryo teratogenesis assay: Xenopus (FETAX) and a metabolic activation system.
    Fort DJ; James BL; Bantle JA
    J Appl Toxicol; 1989 Dec; 9(6):377-88. PubMed ID: 2613998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase III interlaboratory study of FETAX. Part 3. FETAX validation using 12 compounds with and without an exogenous metabolic activation system.
    Bantle JA; Finch RA; Fort DJ; Stover EL; Hull M; Kumsher-King M; Gaudet-Hull AM
    J Appl Toxicol; 1999; 19(6):447-72. PubMed ID: 10547627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FETAX Assay for Evaluation of Developmental Toxicity.
    Mouche I; Malésic L; Gillardeaux O
    Methods Mol Biol; 2017; 1641():311-324. PubMed ID: 28748472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the toxicity and teratogenity of six commercial textile dyes using the frog embryo teratogenesis assay-Xenopus.
    Birhanli A; Ozmen M
    Drug Chem Toxicol; 2005; 28(1):51-65. PubMed ID: 15720035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of acetaminophen-induced developmental toxicity using FETAX.
    Fort DJ; Rayburn JR; Bantle JA
    Drug Chem Toxicol; 1992; 15(4):329-50. PubMed ID: 1459044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the developmental toxicity of nicotine and cotinine with frog embryo teratogenesis assay: Xenopus.
    Dawson DA; Fort DJ; Smith GJ; Newell DL; Bantle JA
    Teratog Carcinog Mutagen; 1988; 8(6):329-38. PubMed ID: 2905544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.